Porfimer sodium - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for porfimer sodium and what is the scope of patent protection?
Porfimer sodium
is the generic ingredient in one branded drug marketed by Pinnacle Biolgs and is included in one NDA. Additional information is available in the individual branded drug profile pages.One supplier is listed for this compound.
Summary for porfimer sodium
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 6 |
Clinical Trials: | 32 |
What excipients (inactive ingredients) are in porfimer sodium? | porfimer sodium excipients list |
DailyMed Link: | porfimer sodium at DailyMed |
Recent Clinical Trials for porfimer sodium
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Cancer Institute (NCI) | Phase 1 |
Roswell Park Cancer Institute | Phase 1 |
Taoyuan General Hospital | Early Phase 1 |
Pharmacology for porfimer sodium
Drug Class | Photoactivated Radical Generator |
Mechanism of Action | Photoabsorption |
Physiological Effect | Photosensitizing Activity |
Anatomical Therapeutic Chemical (ATC) Classes for porfimer sodium
US Patents and Regulatory Information for porfimer sodium
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pinnacle Biolgs | PHOTOFRIN | porfimer sodium | INJECTABLE;INJECTION | 020451-001 | Dec 27, 1995 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for porfimer sodium
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pinnacle Biolgs | PHOTOFRIN | porfimer sodium | INJECTABLE;INJECTION | 020451-001 | Dec 27, 1995 | ⤷ Sign Up | ⤷ Sign Up |
Pinnacle Biolgs | PHOTOFRIN | porfimer sodium | INJECTABLE;INJECTION | 020451-001 | Dec 27, 1995 | ⤷ Sign Up | ⤷ Sign Up |
Pinnacle Biolgs | PHOTOFRIN | porfimer sodium | INJECTABLE;INJECTION | 020451-001 | Dec 27, 1995 | ⤷ Sign Up | ⤷ Sign Up |
Pinnacle Biolgs | PHOTOFRIN | porfimer sodium | INJECTABLE;INJECTION | 020451-001 | Dec 27, 1995 | ⤷ Sign Up | ⤷ Sign Up |
Pinnacle Biolgs | PHOTOFRIN | porfimer sodium | INJECTABLE;INJECTION | 020451-001 | Dec 27, 1995 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
EU/EMA Drug Approvals for porfimer sodium
Company | Drugname | Inn | Product Number / Indication | Status | Generic | Biosimilar | Orphan | Marketing Authorisation | Marketing Refusal |
---|---|---|---|---|---|---|---|---|---|
Pinnacle Biologics B.V. | PhotoBarr | porfimer sodium | EMEA/H/C/000493 Photodynamic therapy (PDT) with PhotoBarr is indicated for: Ablation of high-grade dysplasia (HGD) in patients with Barrett's Oesophagus (BO) |
Withdrawn | no | no | no | 2004-03-25 | |
>Company | >Drugname | >Inn | >Product Number / Indication | >Status | >Generic | >Biosimilar | >Orphan | >Marketing Authorisation | >Marketing Refusal |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.